DIAGNOSIS AND MANAGEMENT OF PULMONARY EMBOLISM

Monday, March 10, 2025

1:30 PM - 2:53 PM ET

Moderator(s)

Kenneth Rosenfield, MD, MHCDS

section head, vascular medicine and intervention
Massachusetts General Hospital
boston, Massachusetts, United States

Disclosure(s): Abbott Vasular: Consulting Fees (e.g., advisory boards) (Ongoing); Akura: Stock-privately held company (Ongoing); Angiodynamics: Consulting Fees (e.g., advisory boards) (Ongoing); Boston Scientific: Consultant (Ongoing), Grant/Research Support (Ongoing); Contego: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing); Cordis: Consulting Fees (e.g., advisory boards) (Ongoing); Fastwave: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing); Imperative Care: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing); Innova Vascular: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing); Inspire MD: Stock-privately held company (Ongoing); Johnson and Johnson: Consulting Fees (e.g., advisory boards) (Ongoing); Medtronic: Consulting Fees (e.g., advisory boards) (Ongoing); MiRus: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing); NAMSA: Consulting Fees (e.g., advisory boards) (Ongoing); Neptune: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing); Philips: Consulting Fees (e.g., advisory boards) (Ongoing); Radiaction: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing); Sonovascular: Stock-privately held company (Ongoing); Thrombolex: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing); Vantis Vascular: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing); Vasorum: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing); Viz.ai: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing); VuMedi: Stock-privately held company (Ongoing)
Rachel Rosovsky, MD, MPH

Associate Professor, Harvard Medical school
Massachusetts General Hospital
Boston, Massachusetts, United States

Disclosure information not submitted.
Andrew SP Sharp, MD

Professor of Cardiology
University College Dublin
Dublin, Ireland

Disclosure(s): AngioDynamics: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Boston Scientific, Medtronic, Recor Medical, Philips, Penumbra: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

Disclosure(s):

Kenneth Rosenfield, MD, MHCDS: Abbott Vasular: Consulting Fees (e.g., advisory boards) (Ongoing); Akura: Stock-privately held company (Ongoing); Angiodynamics: Consulting Fees (e.g., advisory boards) (Ongoing); Boston Scientific: Consultant (Ongoing), Grant/Research Support (Ongoing); Contego: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing); Cordis: Consulting Fees (e.g., advisory boards) (Ongoing); Fastwave: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing); Imperative Care: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing); Innova Vascular: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing); Inspire MD: Stock-privately held company (Ongoing); Johnson and Johnson: Consulting Fees (e.g., advisory boards) (Ongoing); Medtronic: Consulting Fees (e.g., advisory boards) (Ongoing); MiRus: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing); NAMSA: Consulting Fees (e.g., advisory boards) (Ongoing); Neptune: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing); Philips: Consulting Fees (e.g., advisory boards) (Ongoing); Radiaction: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing); Sonovascular: Stock-privately held company (Ongoing); Thrombolex: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing); Vantis Vascular: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing); Vasorum: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing); Viz.ai: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing); VuMedi: Stock-privately held company (Ongoing)

Rachel Rosovsky, MD, MPH: Boston Scientific Corporation: Consultant (Ongoing); Inquis Medical: Consultant (Ongoing); Janssen Pharmaceuticals: Consultant (Ongoing); Penumbra, Inc.: Consultant (Ongoing), Global PI for International device trial; research funds go to my institution (Ongoing), Grant/Research Support (Ongoing)

Andrew SP Sharp, MD: AngioDynamics: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Boston Scientific, Medtronic, Recor Medical, Philips, Penumbra: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)